糖尿病与外周动脉疾病相关截肢后对侧大截肢的系统评价与汇总荟萃分析
汇总非索引侧大截肢发生率为每100人年6例(95%CI 3-9),异质性高(I2=98.93%),汇总死亡率为38%(95%CI 30-47%),双侧大截肢率为12%(95%CI 8-18%)。
要点
- 非索引侧大截肢汇总发生率为每100人年6例(95%CI 3-9)。
- 汇总死亡率为38%(95%CI 30-47%),双侧大截肢率为12%(95%CI 8-18%)。
- 随访时间越长,报告的发生率越低(P<.001)。
核心结论
- 非索引侧大截肢在外周动脉疾病和糖尿病相关肢体疾病患者中持续存在风险。
- 研究结果支持进行结构化双侧肢体监测和早期非索引侧风险分层,以指导全面的保肢治疗。
研究设计与样本
- 系统检索PubMed(MEDLINE)、Embase和Scopus截至2026年1月,遵循PRISMA指南。
- 纳入报告成人外周动脉疾病、慢性肢体威胁性缺血、糖尿病相关肢体疾病或既往同侧大截肢后对侧膝上或膝下截肢的研究。
- 采用单臂随机效应荟萃分析,使用限制性最大似然(REML)估计量,对效应量进行对数转换。
主要发现
- 非索引侧大截肢汇总发生率为每100人年6例(95%CI 3-9),异质性显著(I2=98.93%)。
- 汇总死亡率为38%(95%CI 30-47%),双侧大截肢汇总率为12%(95%CI 8-18%)。
- 非索引侧小截肢汇总率为11%(95%CI 3-37%),非索引侧血运重建率为19%(95%CI 6-47%),非索引侧慢性肢体威胁性缺血发生率为32%(95%CI 11-64%)。
- 随访时间越长,报告的发生率越低(P<.001)。
关键数值与推荐
- 按临床表型(慢性肢体威胁性缺血 vs 非慢性肢体威胁性缺血外周动脉疾病或糖尿病 vs 同侧大截肢后)分层,差异无统计学意义(P=.622)。
- 按地理区域(美国 vs 国际)分层,差异无统计学意义(P=.662)。
- 按研究时代(现代2010-2025 vs 传统2010年前)分层,差异无统计学意义(P=.893)。
- 按糖尿病患病率分层,差异无统计学意义(P=.127)。
临床怎么用
- 对外周动脉疾病和糖尿病相关肢体疾病患者应进行结构化双侧肢体监测。
- 早期识别非索引侧肢体风险,以指导全面的保肢治疗。
局限性
- 异质性高(I2=98.93%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Major amputation remains a devastating and understudied outcome in patients with peripheral artery disease (PAD), chronic limb-threatening ischemia (CLTI), and diabetes mellitus (DM)-related limb disease. Although modern vascular care emphasizes index and symptomatic limb surveillance, the population-level risk of non-index limb (NIL) major amputation remains incompletely defined. We performed a systematic review and meta-analysis to quantify NIL major amputation incidence and evaluate factors associated with contralateral limb loss. DESIGN/METHOD: A systematic search of PubMed (MEDLINE), Embase, and Scopus through January 2026 was conducted in accordance with PRISMA guidelines. Studies reporting contralateral above- or below-knee amputation in adults with PAD, CLTI, DM-related limb disease, or prior ipsilateral major amputation were included. Single-arm random-effects meta-analysis using the restricted maximum likelihood (REML) estimator was performed with log-transformed effect sizes. Subgroup analyses were conducted by clinical phenotype, geographic location, study era, and DM prevalence. Secondary outcomes included overall mortality, bilateral major amputation, NIL minor amputation, NIL revascularization, and development of NIL CLTI. RESULTS: Seventeen cohorts encompassing 30,359 patients were included. The pooled incidence of NIL major amputation was 6 per 100 person-years (95% CI, 3-9), with substantial heterogeneity (I2=98.93%). Meta-regression showed no significant differences by clinical phenotype (P=.622), geographic region (P=.662), study era (P=.893), or DM prevalence (P=.127). Clinical phenotypes included CLTI versus non-CLTI PAD or DM versus post-ipsilateral major amputation. Geographic region was divided into United States and international studies. Study era was divided into modern (2010-2025) and legacy (pre-2010) studies. Longer follow-up duration was inversely associated with reported incidence (P<.001). Pooled mortality rate was 38% (95% CI, 30-47%), and the pooled rate of bilateral major amputation was 12% (95% CI, 8-18%). Other secondary outcomes included a pooled NIL minor amputation rate of 11% (95% CI, 3-37%), NIL revascularization rate of 19% (95% CI, 6-47%), and NIL CLTI development rate of 32% (95% CI, 11-64%). CONCLUSIONS: NIL major amputation remains a persistent risk in PAD and DM-related limb disease. These findings support the need for structured bilateral limb surveillance and early NIL risk stratification to inform comprehensive limb preservation care.
引用
- Han K, Muro A, Sun K, et al. Contralateral Major Amputation Following Diabetes- and Peripheral Artery Disease-Related Limb Loss: A Systematic Review and Pooled Meta-Analysis. J Vasc Surg. 2026. PMID: 42962863. doi:10.1016/j.jvs.2026.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。